Catalyst Event
Alteogen Inc (196170) · Other
From Akros SCHK HK-Korea Quality Factor Index (ASHKQLT)
6/9/2026, 12:00:00 AM
Alteogen is scheduled to present research results on the subcutaneous formulation of Antibody-Drug Conjugates (ADCs) using its ALT-B4 technology at the 'World ADC Asia 2026' forum, scheduled for June 9-11. Low market impact is expected as it is a research presentation, scheduled.
Korean Translation
2026년 6월 9일부터 11일까지 열리는 '월드 ADC 아시아 2026' 포럼에서 자사의 ALT-B4 기술을 활용한 항체-약물 접합체(ADC)의 피하주사 제형 연구 결과를 발표할 예정임. 초기 연구 결과 발표로 시장 영향력은 제한적일 것으로 예상됨.
Related Recent Events
Shanghai Chicmax Cosmetic Co Ltd (2145) · Other
Final dividend of 0.75 yuan per share for fiscal year 2025 with an ex-dividend date of May 12, 2026 (Medium importance as dividend payouts typically support stock price) scheduled.
5/12/2026, 12:00:00 AM
SK Hynix Inc (000660) · Earnings Release
SK Hynix is scheduled to announce its Q1 2026 earnings results on April 29, 2026. Low importance is assigned as the market anticipates the upcoming data, scheduled.
4/29/2026, 12:00:00 AM
HD Hyundai Heavy Industries Co Ltd (329180) · Earnings Release
Q1 2026 earnings release is scheduled.
4/23/2026, 12:00:00 AM
Fuyao Glass Industry Group Co Ltd (3606) · Other
Annual General Meeting for FY2025 and class shareholder meetings for A and H shares scheduled for April 21, 2026, to approve the profit distribution plan and amend the Articles of Association; neutral impact expected as these are routine administrative meetings scheduled
4/21/2026, 12:00:00 AM
Contemporary Amperex Technology Co Ltd (3750) · Other
Ex-dividend date on April 10, 2026, for a final cash dividend of RMB 21.78 per 10 shares for the year ended December 31, 2025, with payment on May 14, 2026 scheduled
4/10/2026, 12:00:00 AM
Huadian Power International Corp Ltd (1071) · Other
An online briefing for the 2025 annual results for investors on April 7, 2026, scheduled.
4/7/2026, 12:00:00 AM